SMTL ID : 6h6q.1

Fragment Derived XIAP inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.63 Å

Oligo State

homo-dimer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.73, C.76, H.93, C.100 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.73, A:C.76, A:H.93, A:C.100 ZN.3: 4 residues within 4Å: Chain B: C.73, C.76, H.93, C.100 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:C.73, B:C.76, B:H.93, B:C.100

2 x FUK: 2-[(2~{R},5~{R})-2-[[(3~{R},5~{R})-3,5-dimethylmorpholin-4-yl]methyl]-5-methyl-piperazin-1-yl]-1-[6-[(~{S})-(4-fluorophenyl)-oxidanyl-methyl]-3,3-dimethyl-2~{H}-pyrrolo[3,2-b]pyridin-1-yl]ethanone(Non-covalent)

FUK.2: 15 residues within 4Å: Chain A: L.65, K.70, V.71, K.72, G.79, L.80, T.81, D.82, W.83, K.84, E.87, Q.92, W.96, Y.97 Chain B: N.22 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:D.82, A:W.83, A:Q.92, A:W.96 Hydrogen bonds: A:K.70, A:T.81, A:E.87 Salt bridges: A:E.87 pi-Cation interactions: A:K.70 FUK.4: 15 residues within 4Å: Chain A: N.22 Chain B: L.65, K.70, V.71, K.72, G.79, L.80, T.81, D.82, W.83, K.84, E.87, Q.92, W.96, Y.97 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:K.70, B:K.70, B:W.83, B:W.96 Hydrogen bonds: B:K.70, B:T.81, B:E.87 Salt bridges: B:E.87 pi-Cation interactions: B:K.70

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Johnson, C.N. et al., A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660). J. Med. Chem. (2018)

Release Date

2018-08-22

Peptides

E3 ubiquitin-protein ligase XIAP: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

E3 ubiquitin-protein ligase XIAP

Related Entries With Identical Sequence